Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

NCT07177612 | Enrolling By Invitation

• 1 other identifier: CIRB2025-0274
• Study Type: observational
• Target: 20,000
• Locations: 3 countries
• Sites: 3

Brief Summary

The goal of this observational study is to assess the if short educational videos about #LILAC-for-Lpa are feasible and accepted in improving the confidence, testing, and management on Lipoprotein(a).

Conditions

Lipoprotein(a); Lipoprotein(a), Hyper-Lp(a)-Emia

Keywords

LILAC-for-Lpa; Educational Videos; lipoprotein(a); Lp(a)

Outcome Measures

Primary Outcomes (1)

• Improvement of Knowledge and awareness of Lp(a)

  Survey and questionnaire on participants to assess knowledge and awareness

  From enrolment to 3 months after

Secondary Outcomes (2)

• Acceptance of Educational Videos

  From point of enrolment to 3 months

• Lipoprotein(a) Testing

  During enrolment to 1 year

Study Arms (2)

Healthcare Professionals

This group includes participants who are doctors, nurses, pharmacists, allied health and healthcare related students

Patients/Family/Public

This group includes participants who have high Lipoprotein(a) levels, or their family members, or members of the public.

Eligibility Criteria

• Age: 16 Years+
• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study populations include healthcare professionals, patients, and members of the public.

You may qualify if:

• Participants include students, participants from institute of higher learning aged 16 and above.
• Participants aged 16 and above regardless of local or overseas, may also be from educational talks that Dr Loh is invited to speak at.
• Patients and members of the public aged 16 and above if they attend lipid awareness educational events.
• Participants aged 16 and above in patient support groups or patient advocacy networks.

You may not qualify if:

• Participants aged below 16 years old.

Sponsors & Collaborators

• Changi General Hospital: lead

Study Sites (3)

Online Portal, Australia

Perth, Australia

Location

Online web portal

Kuala Lumpur, Malaysia

Location

Changi General Hospital

Singapore, Singapore

Location

Related Publications (2)

• Loh WJ, Pang J, Simon O, Chan DC, Watts GF. Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore. Front Cardiovasc Med. 2025 Feb 14;12:1527351. doi: 10.3389/fcvm.2025.1527351. eCollection 2025.

  PMID: 40027516 BACKGROUND

• Loh WJ, Watts GF, Lum E. A short educational video for improving awareness and confidence of healthcare professionals in managing lipoprotein(a): a pilot study based on LILAC-for-Lp(a). Eur J Cardiovasc Nurs. 2025 Jul 21;24(5):796-799. doi: 10.1093/eurjcn/zvaf052. No abstract available.

  PMID: 40156158 BACKGROUND

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Primary Investigator (Senior consultant endocrinologist)

Study Record Dates

• First Submitted: September 10, 2025
• First Posted: September 17, 2025
• Study Start: September 9, 2025
• Primary Completion (Estimated): August 1, 2028
• Study Completion (Estimated): December 1, 2028
• Last Updated: September 22, 2025

Record last verified: 2025-09

Data Sharing

• IPD Sharing: Will not share

Locations

SG (1); MY (1); AU (1)